9 Best Auto Stocks to Buy Now
According to figures issued by the European Automobile Manufacturers' Association (ACEA) on December 23, European new car sales increased year over year in November for the fifth consecutive month, due...
10 Best Long-Term Investments for Kids
By late 2025, long-term investing for children has evolved from simple college savings into a full “cradle-to-retirement” wealth-building ecosystem.
Hedge Funds
News & Analysis
Top Fund Managers
Best Performing Funds
Featured Content
Insider Trading
News & Analysis
Latest Insider Purchases
Gabelli bought 167,500 Gabelli Equity Trust Inc shares at $10.00
Gabelli bought 500,000 Gabelli Equity Trust Inc shares at $10.00
Globalharvest bought 59,761 Mission Produce Inc. shares at $11.60
Globalharvest bought 13,679 Mission Produce Inc. shares at $11.64
Globalharvest bought 15,365 Mission Produce Inc. shares at $11.60
Latest Insider Sales
Walker sold 500 Alphabet Inc. shares at $316.52
Walker sold 6,090 Alphabet Inc. shares at $315.26
Walker sold 11,239 Alphabet Inc. shares at $314.61
Ugwumba sold 3,350 Clene Inc. shares at $6.32
Ugwumba sold 1,490 Clene Inc. shares at $6.27
Featured Content
Do not Miss
Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB)
On December 15, TheFly published that Luke Sergott, a Barclays analyst, lifted the price objective for Pacific Biosciences of California, Inc.
Cathie Wood’s ARK Investment Buys 755K Shares Of Recursion Pharmaceuticals, Inc. (RXRX)
On December 17, 2025, JPMorgan raised Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) from Neutral to Overweight, with a price objective of $11 instead of $10.
Chardan Maintains A Buy Recommendation On CRISPR Therapeutics AG (CRSP)
TheFly published on November 26, 2025, that Chardan kept its buy recommendation on CRISPR Therapeutics AG (NASDAQ:CRSP) while reducing its price target from $82 to $74.
Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST)
TheFly reported on December 15, 2025, that Barclays kept its Overweight rating and boosted its price objective for Twist Bioscience Corporation (NASDAQ:TWST) from $37 to $39.
Morgan Stanley Initiates Coverage Of Veracyte, Inc. (VCYT)
The Fly reported on December 2, 2025, that Morgan Stanley began covering Veracyte, Inc. (NASDAQ:VCYT) with an Underweight rating and a price target of $48, up from $40.
Canaccord Lowers Price Objective On Tempus AI, Inc. (TEM)
TheFly reported on December 22, 2025, that Canaccord reduced the price objective for Tempus AI, Inc. (NASDAQ:TEM) to $80 from $95. The shares were still rated as a buy by analyst Kyle Mikson.
What Do Analysts Think About GeneDx Holdings Corp. (WGS)?
TheFly reported that on December 22, 2025, GeneDx Holdings Corp. (NASDAQ:WGS) lifted its price objective at Canaccord from $160 to $170. Canaccord continued to rate the shares as a Buy.
H.C. Wainwright Maintains A Buy Rating On Wave Life Sciences Ltd. (WVE)
TheFly reports that on December 19, 2025, H.C. Wainwright upgraded Wave Life Sciences Ltd. (NASDAQ:WVE)’s price target from $22 to $30. Analyst Andrew Fein upheld the Buy rating. H.C.
Beam Therapeutics Inc. (BEAM) Reports Updated Data From BEACON Phase 1/2 trial Of Ristoglogene
TheFly reported on December 2, 2025, that Beam Therapeutics Inc.
Prime Medicine, Inc. (PRME) Announces NEJM Publication Of PM359 Data
Prime Medicine, Inc.
10 Big Names Crumbling Before 2026
ASP Isotopes extended its losing streak to a third day on Tuesday, shedding 5.08 percent to close at $5.42 apiece as investors mirrored a key executive’s disposition of a significant stake in the company...
BofA Raises Thermo Fisher (TMO) Target as Biopharma Recovery Comes Into View
On December 15, Bank of America raised its price target on Thermo Fisher Scientific Inc. (NYSE:TMO) to $700 from $650 and kept a Buy rating on the shares.
Eli Lilly (LLY) Moves Fast to Secure Lead in India’s Obesity Drug Market
Eli Lilly and Company (NYSE:LLY) is moving quickly to lock in its position in India’s fast-growing obesity drug market.
Johnson & Johnson (JNJ) Ends Mid-Stage Eczema Study After Missing Efficacy Bar
On December 26, Johnson & Johnson (NYSE:JNJ) said it ended a mid-stage study of an experimental drug for patients with moderate to severe atopic dermatitis.
BofA Cuts AbbVie (ABBV) Target While Maintaining Neutral View
On December 15, BofA lowered the firm’s price target on AbbVie Inc. (NYSE:ABBV) to $233 from $248 and kept a Neutral rating.
FDA Fast-Tracks Two Merck (MRK) Drugs With Blockbuster Potential
On December 17, the US Food and Drug Administration moved to fast-track reviews of two experimental Merck & Co., Inc.
Pfizer (PFE) Braces for Bumpy Years as Growth Pushed Out to 2029
On December 16, Pfizer Inc. (NYSE:PFE) said the next few years are expected to be bumpy, starting in 2026.
CVS Gets Higher Target as Bernstein Cites Management Confidence
On December 12, Bernstein raised the firm’s price target on CVS Health Corporation (NYSE:CVS) to $87 from $86 and kept a Market Perform rating after what it described as a very positive Investor Day...
Goldman Sachs Raises Bristol-Myers (BMY) Target, Keeps Neutral Rating
Bristol-Myers Squibb Company (NYSE:BMY) presents a measured balance between risk and reward. The stock offers a 4.6% dividend yield, and the payout ratio sits near 85%.
McKesson (MCK) Gets Higher Target at Deutsche Bank Despite Planned Spin-Off
On December 10, Deutsche Bank analyst George Hill raised the firm’s price target on McKesson Corporation (NYSE:MCK) to $904 from $861 and kept a Buy rating on the shares.
BofA Downgrades Zoetis (ZTS) to Neutral, Cuts Price Target
In other news, on December 5, Zoetis Inc. (NYSE:ZTS) announced that Health Canada approved Portela™ (relfovetmab injection) for the relief of pain linked to osteoarthritis, or OA, in cats.
Abbott (ABT) Wins FDA Approval for Volt PFA System in AFib Treatment
On December 22, Abbott Laboratories (NYSE:ABT) said the US Food and Drug Administration has approved the company’s Volt™ PFA System to treat patients with atrial fibrillation, or AFib.
Gilead (GILD) Reaches Pricing Agreement with US Government to Lower Drug Costs
On December 19, Gilead Sciences, Inc. (NASDAQ:GILD) announced an agreement with the US government aimed at lowering drug costs for Americans.
Barclays Initiates Viatris (VTRS) with Overweight as Pharma Sentiment Improves
On December 9, Barclays analyst Glen Santangelo initiated coverage of Viatris Inc. (NASDAQ:VTRS) with an Overweight rating and a $15 price target.
S&P Global (SPGI) Partners with Google Cloud to Accelerate AI Transformation
On December 10, S&P Global Inc. (NYSE:SPGI) announced a multi-year strategic partnership with Google Cloud.
BofA Raises Coca-Cola (KO) Target as 2026 Consumption Growth Remains Unclear
On December 19, BofA analyst Peter Galbo raised the price target on The Coca-Cola Company (NYSE:KO) to $85 from $80 and kept a Buy rating.
Bernstein Raises Caterpillar (CAT) Target as 2026 Recovery Comes Into View
On December 19, Bernstein raised its price target on Caterpillar Inc. (NYSE:CAT) to $630 from $557 and kept a Market Perform rating.
Ecolab (ECL) Target Trimmed at Citi Amid Shifting Views on Chemicals
On December 18, Citi analyst Patrick Cunningham lowered the price target on Ecolab Inc. (NYSE:ECL) to $315 from $323 and maintained a Buy rating.
ADP Downgraded to Underperform as Jefferies Flags Structural Headwinds
On December 16, Jefferies analyst Samad Samana downgraded Automatic Data Processing, Inc. (NASDAQ:ADP) to Underperform from Hold and cut the price target to $230 from $245.
11 Best NYSE Stocks Under $5 to Buy
Investors often refer to stocks trading below $5 per share as small capitalization stocks.
Colgate-Palmolive (CL) Target Raised as Analysts Split on 2026 Staples Outlook
On December 19, BofA raised its price target on Colgate-Palmolive Company (NYSE:CL) to $90 from $88 and kept a Buy rating.
Dover (DOV) Price Target Lifted as BofA Sees Momentum Carrying Into 2026
On December 15, BofA analyst Andrew Obin raised the price target on Dover Corporation (NYSE:DOV) to $240 from $225 and maintained a Buy rating.
Hedge Fund Resource Center Lists
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending
New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)
J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum
11 Best Cancer Stocks to Buy Right Now
40 Most Unfriendly Countries in the World
30 Unhappiest Countries in the World in 2025
Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut
5 Countries with the Most Beautiful Women in the World
20 Countries with the Most Beautiful Women in the World
20 US Cities with the Highest Homeless Population Per Capita
20 Countries with the Highest Homeless Population
12 Countries with the Highest Bond Yields in the World
20 Countries with the Most Battle Tanks in the World
12 Best Nasdaq Stocks Under $20 to Buy Now
10 Best Low Beta Tech Stocks to Buy According to Analysts
10 Worst Performing Currencies of 2024
15 States with the Best Weed in America
16 Countries with the Largest Proven Oil Reserves in the World
16 Highest Quality Chocolate Brands in the US
20 Countries with the Strongest Armies in the World
Top 13 English Speaking Countries in Asia
20 States with Highest Female to Male Ratio in the US
40 Best Places to Visit in Europe Before You Die
20 States with the Lowest Life Expectancy in the US
25 Cities with the Highest Homeless Population in the World
20 Countries With The Best English Accent in The World
30 Cities with the Highest Weed Consumption in the US
25 Countries with the Highest Alcohol Consumption per Capita
10 Best Gold Stocks Under $30
10 Best Genomics Stocks To Buy Right Now
20 Countries with the Best Economy in the World in 2024
30 Cheapest Countries in the World in 2024
15 Healthiest Countries in Europe
15 Healthiest Countries In Africa
25 Most Tropical Cities in the US
15 Most Underrated States in the US
13 Best Cheap Perfumes for Women That Smell Amazing
Best Cheap Perfume for Women That Smells Amazing
20 Most Industrialized Countries in Asia
The Most Successful Celebrity Beauty Company in the World
15 Most Successful Celebrity Beauty Companies in the World
20 Best Places For Sex Tourism in the World
Top 20 U.S. Cities with the Highest Murders in 2024
26 Most Dangerous Prisons In The World
30 Cities with The Highest Murders Per Capita in 2024 in the World
Top 10 Affordable Cities to Live in the US in 2024
20 Budget-Friendly Corporate Gifts for Employees
30 US Cities With Highest Homicide Rates In 2024
20 Countries With Darkest Skin Color in the World
25 Easiest Countries to Get Laid in 2024
